Abstract
The interventional radiologist who establishes a percutaneous tumor ablation program will likely become skilled in liver tumor ablation before attempting to treat renal cell carcinoma. Liver tumors are more common than primary renal tumors, and most patients with liver tumors are not surgical candidates. Thus, a steady influx of patients eligible for percutaneous ablation of hepatic tumors can be expected in many centers. In contrast, surgical removal remains the standard therapy for small renal cell carcinomas, and most patients can undergo resection (1). Nevertheless, with the incidence of renal cell carcinoma (RCC) increasing and with the aging population in the United States, the number of patients with small RCCs who are not good surgical candidates is expected to increase (2–4). Thus, from time to time, the radiologist experienced in percutaneous tumor ablation can expect to encounter patients for whom percutaneous treatment of RCC is the only option or the most reasonable one.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Novick AC, Campbell SC. Renal tumors. In: Walsh PC, ed. Campbell’s Urology. 8th ed. Philadelphia: WB Saunders, 2002:2672–2731.
Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin 2000;50:7–33.
Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998;51:203–205.
Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628–1631.
Kidney. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997:231–234.
Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000;217:665–672.
Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: clinical experience and technical success in 42 tumors. Radiology 2003;226(2):417–424.
Gettman MT, Blute ML. Update on pathologic staging of renal cell carcinoma. Urology 2002;60:209–217.
Medeiros LJ, Jones EC, Aizawa S, et al. Grading of renal cell carcinoma. Cancer 1997;80:990–991.
Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma. Cancer 1997;80:987–989.
Swanson DA, Rothenberg HJ, Boynton AL, et al. Future prognostic factors for renal cell carcinoma. Cancer 1997;80:997–998.
Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001;166:6–18.
Reddan DN, Raj GV, Polascik TJ. Management of small renal tumors: an overview. Am J Med 2001;110:558–562.
Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR 2000;174:323–331.
Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761–768.
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999;210:655–661.
Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion mediated tissue cooling limit coagulation necrosis? J Vasc Intervent Radiol 1998;9:101–111.
Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002;167:10–15.
Mayo-Smith WW, Dupuy DE, Ridlen MS, Cronan JJ. Radiofrequency ablation of solid renal masses: results of 26 consecutive treatments in 22 patients. AJR 2003;180(6):1503–1508.
Lewin JS, Connell CF, Duerk JL, et al. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 1998;8:40–47.
Wood BJ, Khan MA, McGovern F, Harisinghani M, Hahn PF, Mueller PR. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol 1999;161:1470–1474.
American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by nonanesthesiologists. Anesthesiology 1996;84:459–470.
Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997;11:251–258.
Zlotta AR, Schulman CC. Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy. Urology 1999;54:382–383.
Dodd GD III, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR 2001;77:777–782.
Dupuy DE, Mayo-Smith WW, Cronan JJ. Imageguided biopsy and radiofrequency ablation of renal masses. Semin Intervent Radiol 2000;17:373–380.
Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000;88:2452–2463.
Gervais DA, O’Neill MJ, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Peritumoral CT changes associated with radio-frequency (RF) ablation of focal renal lesions: description, incidence, and significance. Radiology 2001;221 (P):180.
de Baere T, Denys A, Kuoch V, Elias D, Vilgrain V, Roche A. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol 2003;13(10):2346–2352.
Zagoria RJ, Chen MY, Kavanagh PV, Torti FM. Radiofrequency ablation of lung metastases from renal cell carcinoma. J Urol 2001;166:1827–1828.
Gervais DA, Arellano R, McDougal WS, McGovern FJ, Mueller PR. Radiofrequency (RF) ablation of metastatic soft tissue tumors of the genitourinary system: indications, results, and the role of RFA after failed conventional therapies. Radiology 2001;221 (P):261.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Gervais, D.A., Müeller, P.R. (2005). Tumor Ablation in the Kidney. In: vanSonnenberg, E., McMullen, W.N., Solbiati, L., Livraghi, T., Müeller, P.R., Silverman, S.G. (eds) Tumor Ablation. Springer, New York, NY. https://doi.org/10.1007/0-387-28674-8_28
Download citation
DOI: https://doi.org/10.1007/0-387-28674-8_28
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95539-1
Online ISBN: 978-0-387-28674-7
eBook Packages: MedicineMedicine (R0)